{"schema_version":"1","generated_at":"2026-11-04T19:14:37.111Z","data_as_of":null,"url":"https://www.findmykol.com/kol/andrew-evens","json_url":"https://www.findmykol.com/kol/andrew-evens/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"andrew-evens","name":"Andrew Evens","credential":"DO, MS","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1265468110"},"summary":"Andrew Evens is a Hematology physician. ClinicalTrials.gov lists 7 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":7,"shown":3,"withheld":4,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01549886","title":"Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Spectrum Pharmaceuticals, Inc","source_url":"https://clinicaltrials.gov/study/NCT01549886","trial_url":"https://www.findmykol.com/trial/NCT01549886"},{"nct":"NCT01216683","title":"Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"ECOG-ACRIN Cancer Research Group","source_url":"https://clinicaltrials.gov/study/NCT01216683","trial_url":"https://www.findmykol.com/trial/NCT01216683"},{"nct":"NCT00734773","title":"Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL","phase":"EARLY_PHASE1","status":"WITHDRAWN","role":"Overall official","sponsor":"Northwestern University","source_url":"https://clinicaltrials.gov/study/NCT00734773","trial_url":"https://www.findmykol.com/trial/NCT00734773"}],"source":"trials"},"payments":{"company_count":7,"program_years":{"first":2021,"last":null},"rows_total":23,"shown":3,"withheld":20,"rows":[{"payer":"Ipsen","program_year":2025,"amount_usd":457050,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265468110"},{"payer":"Genentech USA, Inc.","program_year":2025,"amount_usd":5462.66,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265468110"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":50.19,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265468110"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1265468110","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":1,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Calquence","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":86.5,"facility_pct":13.5},"source":"medicare"},"funding":{"award_count":5,"fiscal_years":{"first":2010,"last":2026},"rows_total":15,"shown":3,"withheld":12,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R01CA262265","title":"Modeling Multi-Source Data in Hodgkin Lymphoma","fiscal_year":2026,"amount_usd":"660541","organization":"TUFTS MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R01CA262265"},{"project":"R01CA262265","title":"Modeling Multi-Source Data in Hodgkin Lymphoma","fiscal_year":2025,"amount_usd":"666718","organization":"TUFTS MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R01CA262265"},{"project":"R01CA262265","title":"Modeling Multi-Source Data in Hodgkin Lymphoma","fiscal_year":2024,"amount_usd":"633900","organization":"TUFTS MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R01CA262265"}],"source":"grants"},"contact":{"address_1":"800 WASHINGTON STREET","address_2":"TUFTS MEDICAL CENTER","city":"Boston","state":"MA","zip":"02111","phone":"617-636-8077","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1265468110","source":"identity"},"similar":[{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":4,"payments":20,"funding":12}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-04-26","provider_certified":"2024-04-26","collected_at":"2026-11-04T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}